This Web site has been sponsored by Pall Corporation in an effort to equip patients with the knowledge they need to understand the risks, benefits and options surrounding blood transfusions. An advocate of patient education and patient protection, Pall has been a committed partner in the hospital and blood banking communities since 1988, delivering the most advanced filtration solutions for the purpose of reducing donor leukocytes that can cause transfusion reactions and complications. As a manufacturer of innovative products for the collection, processing and purification of blood, Pall has been working to further enhance the safety of the world's blood supply and has been instrumental in assisting several countries adopt universal blood filtration policies. The hope is that someday every person, any where around the globe, will have the opportunity to receive leukocyte reduced blood products. Pall Corporation is a specialty materials and engineering company with the broadest-based filtration and separations capabilities in the world. Pall serves a diverse, global customer base in three major market: Health Care, Aeropower and Fluid Processing. The company's proprietary products are used to purify raw materials, keep equipment running efficiently, ensure product quality, and clean up and minimize waste. To learn more about Pall Corporation, please visit their Web site.